18 Results for "

α1β3γ2

" in MedChemExpress (MCE) Product Catalog:
Products (18)

18 Results for "α1β3γ2" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-16579
CAS No.: 56776-32-0
Synonyms: HOE 36-801 hydrochloride
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

Etifoxine hydrochloride, a non-benzodiazepine GABAergic compound, is a positive allosteric modulator of α1β2γ2 and α1β3γ2 subunit-containing GABAA receptors. Etifoxine hydrochloride reveals anxiolytic and anticonvulsant properties in rodents .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-16579A
CAS No.: 21715-46-8
Synonyms: HOE 36-801
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

Etifoxine, a non-benzodiazepine GABAergic compound, is a positive allosteric modulator of α1β2γ2 and α1β3γ2 subunit-containing GABAA receptors. Etifoxine reveals anxiolytic and anticonvulsant properties in rodents .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-100370
CAS No.: 342652-67-9
Purity:  99.71%
Target:  

GABA Receptor

Research Areas:  

Cancer

MRK-016 is a selective, orally bioavailable inverse agonist of GABAA α5 receptor, with an EC50 of 3 nM for GABAA α5, and Kis of 0.83, 0.85, 0.77 and 1.4 nM for human GABAA α1β3γ2, GABAA α2β3γ2, GABAA α3β3γ2, and GABAA α5β3γ2, respectively; MRK-016 also readily penetrates the CNS.
loading...
    loading...
Cat. No.: HY-15831
CAS No.: 1213669-91-0
Purity:  99.71%
L-838417-d9 is the deuterium labeled L-838417 (HY-W009009). L-838417 is a selective partial agonist at the α2, α3 and α5 subtypes of the GABAA receptor and an antagonist at the α1, with binding Ki values of 0.79 nM, 0.67 nM, 1.67 nM, 267 nM, 2.25 nM and 2183 nM for α1β3γ2, α2β3γ2, α3β3γ2, α4β3γ2, α5β3γ2 and α6β3γ2. L-838417 has anti-anxiety activity .
loading...
    loading...
Cat. No.: HY-103520
CAS No.: 374084-31-8
Purity:  99.94%
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

DS2 is a selective positive allosteric modulator of δ-GABAA receptor. DS2 selectively potentiates GABA responses mediated by α4β3δ receptor. DS2 does not enhance activity at α4β3γ2 and α1β3γ2 receptors. DS2 relieves pain and has the potential for sleep disorders research .
loading...
    loading...
Cat. No.: HY-B1803A
CAS No.: 1135210-68-2
Synonyms: ICI 136753 hydrochloride
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

Tracazolate (ICI 136753) hydrochloride is a potent GABAA receptor modulator. Tracazolate hydrochloride has selectivity for β3 and potentiates α1β1γ2s (EC50=13.2 μM), α1β3γ2 (EC50=1.5 μM). Tracazolate hydrochloride has the potency (EC50) determined by the nature of the third subunit (γ1-3, δ, ε) within the receptor complex. Tracazolate hydrochloride possesses anxiolytic and anticonvulsant activity .
loading...
    loading...
Cat. No.: HY-W009009
CAS No.: 286456-42-6
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

L-838417 is a selective partial agonist at the α2, α3 and α5 subtypes of the GABAA receptor and an antagonist at the α1, with binding Ki values of 0.79 nM, 0.67 nM, 1.67 nM, 267 nM, 2.25 nM and 2183 nM for α1β3γ2, α2β3γ2, α3β3γ2, α4β3γ2, α5β3γ2 and α6β3γ2. L-838417 has anti-anxiety activity .
loading...
    loading...
Cat. No.: HY-107489
CAS No.: 883093-10-5
Purity:  99.30%
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

RO 4938581 is a potent and selective GABAA α5 inverse agonist, with a Ki of 4.6 nM for GABAA α5β3γ2a, and shows a lower affinity at α1β3γ2a, α2β3γ2a, α3β3γ2a (Ki, 174, 185, 80 nM, respectively); RO 4938581 is used in the research of cognitive dysfunction.
loading...
    loading...
Cat. No.: HY-170902
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

GABAA receptor modulator-4 (Compound 4) is the negative allosteric modulator for GABAA receptor. GABAA receptor modulator-4 inhibits α1β3γ2 GABAA receptor-mediated peak and steady currents with IC50 of 10 μM and 10 μM .
loading...
    loading...
Cat. No.: HY-170903
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

GABAA receptor modulator-3 (compound 3b) is a positive allosteric modulator (PAM). GABAA receptor modulator-3 inhibits α1β3γ2 GABAAR at peak and steady state currents with IC50s of 671 and 64 μM, respectively .
loading...
    loading...
Cat. No.: HY-16579AS2
CAS No.: 1346598-10-4
Etifoxine-d5 is the deuterium labeled Etifoxine. Etifoxine, a non-benzodiazepine GABAergic compound, is a positive allosteric modulator of α1β2γ2 and α1β3γ2 subunit-containing GABAA receptors. Etifoxine reveals anxiolytic and anticonvulsant properties in rodents .
loading...
    loading...
Cat. No.: HY-16579AR
CAS No.: 21715-46-8
Synonyms: HOE 36-801 (Standard)
Research Areas:  

Neurological Disease

Etifoxine (Standard) is the analytical standard of Etifoxine. This product is intended for research and analytical applications. Etifoxine, a non-benzodiazepine GABAergic compound, is a positive allosteric modulator of α1β2γ2 and α1β3γ2 subunit-containing GABAA receptors. Etifoxine reveals anxiolytic and anticonvulsant properties in rodents .
loading...
    loading...
Cat. No.: HY-130349
CAS No.: 121124-29-6
Synonyms: L-656,748
Target:  

GABA Receptor

Research Areas:  

Infection

Emamectin B1a (L-656,748) is a semisynthetic derivative of avermectin B1a that binds to GABA receptors (Ki=17.6 nM in rat brain membranes) and enhances GABA responses. Emamectin B1a acitivates GABAA receptors α1β1γ2, α1β2γ2, and α1β3γ2 with IC50s of 57, 210, and 49.8 nM, respectively. Emamectin B1a also binds to glycine receptors, inhibiting glycine receptors with an IC50=218 nM in rat spinal cord. Emamectin B1a (1.067 ng/mL) caused 90% mortality of S. exigua larvae in foliar spray bioassays and topical application, making it more toxic than avermectin B1.
loading...
    loading...
Cat. No.: HY-175251
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

GABAA receptor modulator-9 is and positive allosteric modulator of a1β2y2 subtype GABAA that can cross the blood-brain barrier. GABAA receptor modulator-9 exhibits comparable activity on α1β2γ2 (EC50: 0.9 μM in oocytes, 0.2 μM in CHO cells) and on α1β2, α3β2γ2 and α1β3γ2 (EC50s of 1.3, 3.4 and 1.1 μM). GABAA receptor modulator-9 significantly suppresses seizure progression and reduces delayed mortality. GABAA receptor modulator-9 can be used for the study of status epilepticus (SE) .
loading...
    loading...
Cat. No.: HY-W009009R
CAS No.: 286456-42-6
Research Areas:  

Neurological Disease

L-838417 (Standard) is the analytical standard of L-838417 (HY-W009009). This product is intended for research and analytical applications. L-838417 is a selective partial agonist at the α2, α3 and α5 subtypes of the GABAA receptor and an antagonist at the α1, with binding Ki values of 0.79 nM, 0.67 nM, 1.67 nM, 267 nM, 2.25 nM and 2183 nM for α1β3γ2, α2β3γ2, α3β3γ2, α4β3γ2, α5β3γ2 and α6β3γ2. L-838417 has anti-anxiety activity .
loading...
    loading...
Cat. No.: HY-16579R
CAS No.: 56776-32-0
Synonyms: HOE 36-801 hydrochloride (Standard)
Research Areas:  

Neurological Disease

Etifoxine (hydrochloride) (Standard) is the analytical standard of Etifoxine (hydrochloride). This product is intended for research and analytical applications. Etifoxine hydrochloride, a non-benzodiazepine GABAergic compound, is a positive allosteric modulator of α1β2γ2 and α1β3γ2 subunit-containing GABAA receptors. Etifoxine hydrochloride reveals anxiolytic and anticonvulsant properties in rodents .
loading...
    loading...
Cat. No.: HY-178782
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

GABAA receptor modulator-11 (Compound 4) is a GABAA receptor modulator. GABAA receptor modulator-11 inhibits anesthetic-induced desensitization of GABAA α1β3γ2 and α1β3 receptors, with IC50 values of 5.1 μM and 3.1 μM, respectively. GABAA receptor modulator-11 can be used for research on central nervous system diseases .
loading...
    loading...
Cat. No.: HY-107489R
CAS No.: 883093-10-5
Research Areas:  

Neurological Disease

RO 4938581 (Standard) is the analytical standard of RO 4938581 (HY-107489). This product is intended for research and analytical applications. RO 4938581 is a potent and selective GABAA α5 inverse agonist, with a Ki of 4.6 nM for GABAA α5β3γ2a, and shows a lower affinity at α1β3γ2a, α2β3γ2a, α3β3γ2a (Ki, 174, 185, 80 nM, respectively); RO 4938581 is used in the research of cognitive dysfunction.
loading...
    loading...
  • 1